Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DOR/TDF/3TC Maintenance Therapy Among Patients Harboring M184V/I Mutation: a Pilot Open-label Study

NCT06034938 is registered in ClinicalTrials.gov with University Hospital, Caen as lead sponsor.

NCT NCT06034938
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06034938 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DOR/TDF/3TC Maintenance Therapy Among Patients Harboring M184V/I Mutation: a Pilot Open-label Study
Lead sponsor
University Hospital, Caen
Phase
Phase 2
Overall status
Recruiting
Start date
February 8, 2024
Completion date
May 1, 2026
Enrollment
32 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hiv